Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 25, 2020
Cash flows from operating activities:
Net income	$ 23,181	$ 9,013
Adjustments to reconcile net income to cash flows provided by operating activities:
Depreciation and amortization	3,661	4,146
Operating (gains), losses and other charges, net	532	1,473
Gains on interest rate swap derivatives, net	(29,733)	0
Amortization of deferred financing costs	344	152
(Gains) losses on investments	8	(116)
Losses on termination of leases	34	28
Deferred income tax expense (benefit)	4,099	(2,577)
Share-based compensation expense (benefit)	3,472	(1,537)
Changes in assets and liabilities:
Receivables	353	15,815
Inventories	13	(4)
Other current assets	5,294	4,111
Other noncurrent assets	(201)	1,578
Operating lease assets and liabilities	(604)	(18)
Accounts payable	1,820	(7,465)
Accrued payroll	(1,704)	(12,783)
Accrued taxes	(380)	(971)
Other accrued liabilities	1,195	(6,337)
Other noncurrent liabilities	(1,149)	(2,607)
Net cash flows provided by operating activities	10,235	1,901
Cash flows from investing activities:
Capital expenditures	(1,583)	(2,818)
Proceeds (costs) from sales of restaurants, real estate and other assets	1,348	(35)
Investment purchases	0	(1,400)
Proceeds from sale of investments	200	0
Collections on notes receivable	215	505
Issuance of notes receivable	0	(408)
Net cash flows provided by (used in) investing activities	180	(4,156)
Cash flows from financing activities:
Revolver borrowings	7,500	102,500
Revolver payments	(2,500)	(24,500)
Long-term debt payments	(473)	(406)
Proceeds from exercise of stock options	116	0
Tax withholding on share-based payments	(1,309)	(3,036)
Deferred financing costs	(8)	0
Purchase of treasury stock	0	(36,008)
Net bank overdrafts	(3,125)	(449)
Net cash flows provided by financing activities	201	38,101
Increase in cash and cash equivalents	10,616	35,846
Cash and cash equivalents at beginning of period	3,892	3,372
Cash and cash equivalents at end of period	$ 14,508	$ 39,218